AIDS models: Microbicides could learn from vaccines [2]

Nature Medicine

Volumn 8, Issue 5, 2002, Pages 425-

  Shattock, Robin J ^a   Doms, Robert W ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NONOXINOL 9;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG EFFICACY; DRUG RESEARCH; LETTER; PRIORITY JOURNAL; VIRUS INHIBITION;

AIDS VACCINES; ANTI-INFECTIVE AGENTS; DRUG DESIGN; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036100217     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0502-425     Document Type: Letter

References (7)

1. AIDS vaccine models: Challenging challenge viruses
2. Chemical condoms' for the prevention of HIV infection: Evaluation of novel agents against SHIV(89.6PD) in vitro and in vivo
3. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120
4. The role of DC-SIGN and DC-SIGNR in HIV and SIV attachment, infection, and transmission
5. The plasma membrane as a combat zone in the HIV battlefield
6. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides
7. Distinct pathogenic sequela in rhesus macaques infected with CCR 5 or CXCR4 utilizing SHIVs